Cairdac manufactures the ALPS™, the first autonomous leadless pacing system that utilizes inertial energy harvesting technology to power itself by capturing the heart's kinetic energy. This eliminates the need for battery replacements, addressing the significant longevity issues faced by traditional and leadless pacemakers.
Funding
$20.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MRFounders
Product
Problem
Traditional pacemakers and leadless pacemakers rely on batteries that eventually deplete, necessitating replacement procedures. These replacements pose complications, risks, and costs for both patients and healthcare systems. Furthermore, current leadless options lack the capability for dual-chamber stimulation.
Solution
Cairdac's ALPS™ (Autonomous Leadless Pacing System) incorporates a patented inertial energy harvesting technology that captures the heart's kinetic energy to power the device, eliminating the need for battery replacements. This autonomous system is implanted endoscopically, reducing the risk of infections and complications. ALPS™ also enables dual-chamber stimulation and real-time monitoring through a holter, addressing limitations of existing leadless pacemakers and offering a cost-effective solution with an extended lifespan.
Target Audience
The primary target audience includes patients requiring cardiac rhythm management, particularly younger patients who would benefit from a longer-lasting device, and healthcare professionals seeking cost-effective and less invasive pacing solutions.
Features
- Inertial energy harvesting module for self-sustaining power.
- Endoscopic implantation to minimize infection risks.
- Dual-chamber stimulation capabilities.
- Human Body Communication transmitter for intercommunication between capsules.
- Real-time monitoring via integrated holter for data collection and sharing.
- Miniature size for less invasive implantation.